Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: Outcomes for patients with E. coli UTIs

British Journal of General Practice

Volumn 56, Issue 530, 2006, Pages 686-692

  Butler, Christopher C ^a   Hillier, Sharon ^a   Roberts, Zoë ^a   Dunstan, Frank ^a   Howard, Anthony ^b   Palmer, Stephen ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

Anti bacterial agents; Cohort study; Drug resistance, bacterial; Primary health care; Treatment outcomes; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DRUG TREATMENT FAILURE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY MEDICAL CARE; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM; URINARY TRACT INFECTION; WORKLOAD;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; WALES; WORKLOAD;

EID: 33748705779     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Einarsson S, Kristjansson M, Kristinsson et al. Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. Scand J Infect Dis 1998; 30(3): 253-256.
2. Feikin DR, Schuchat A, Kolczak M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1999. Am J Public Health 2000; 90(2): 223-229.
3. Gupta K, Stamm WE. Outcomes associated with trimethoprim/ sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents 2002; 19(6): 554-556.
4. Butler CC, Rollnick S, Maggs-Rapport F, et al. Understanding the culture of prescribing: A qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998; 317: 637-642.
5. MeRec. Urinary tract infection. MeReC Bulletin 1995; 6(8): 29-32.
6. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002; 168(4 Pt 2): 1720-1722.
7. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135(1): 41-50.
8. McCarty JM, Richard G, Huck W, et al. A randomized trial of short-course of ciprofloxacin, ofloxacin, or trimethoprim /sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999; 106(3): 292-299.
9. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000; 283(12): 1583-1590.
10. Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005; 293(8): 949-955.
11. Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother 1995; 350(1): 129-137.
12. Nicolle LE, Hoepelman AI, et al. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand J Infect Dis 1993; 25(5): 631-637.
13. Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34(9): 1165-1169.
14. Steinke DT, Seaton RA, Phillips G, MacDonald TM, et al. Factors associated with trimethoprim-resistant bacteria isolated from urine samples. J Antimicrob Chemother 1999; 43(6): 841-843.
15. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999; 14(10): 606-609.